Clinical Trials Browser

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT07359040 2026-03-12

Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer

Active not recruiting

80 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07428252 2026-02-25

Gastrointestinal Microbiome and Response to Immunotherapy in Metastatic Malignant Melanoma

Phase NA Active not recruiting

150 enrolled

Dermatologic

Melanoma

NCT05358938 2026-02-06

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Phase EARLY_PHASE1 Active not recruiting

22 enrolled

Dermatologic

Melanoma, Motor Activity, Skin Neoplasms, Carcinoma, Merkel Cell

NCT05621707 2026-02-02

RICE

Phase 2 Active not recruiting

50 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT06710847 2026-02-02

SYLVER

Phase 1/2 Active not recruiting

14 enrolled

GastrointestinalGynecologic

Turcot syndrome, Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07339488 2026-01-14

ILDR-03

Phase 2 Active not recruiting

43 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05013450 2025-12-17

Dupilumab_Metastatic NSCLC

Phase 1/2 Active not recruiting

33 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07256002 2025-12-01

Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy

Active not recruiting

10,000 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05241340 2025-10-24

RAD-VACCINE

Phase 2 Active not recruiting

33 enrolled

Genitourinary

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT04225039 2025-08-15

Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma

Phase 2 Active not recruiting

39 enrolled 10 charts

CNS

Glioblastoma

NCT04907370 2025-07-16

DIAMOND

Phase 3 Active not recruiting

532 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT06076135 2025-06-15

ILDR-01

Phase 2 Active not recruiting

16 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT05704985 2025-05-29

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

Phase 1 Active not recruiting

39 enrolled

DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Kidney Neoplasms, Neoplasms, Pancreatic Neoplasms, Skin Neoplasms, Colorectal Neoplasms

Clinical Trials

PD1-VEN-CAG

Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer

Gastrointestinal Microbiome and Response to Immunotherapy in Metastatic Malignant Melanoma

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

RICE

SYLVER

ILDR-03

Dupilumab_Metastatic NSCLC

Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy

RAD-VACCINE

Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma

DIAMOND

ILDR-01

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors